Grant: Engage Grants Program
University of Toronto
$25,000.00
Investigation of nerve fibre imaging in radiosurgery
FY 2015-16
Summary
20-40% of all cancer patients develop brain metastases (BM). The incidence is likely to increase as cancer patients are living longer. Effective treatment provides patients with a high quality of life, but must be efficient and accurate due to increasing patient numbers and the risks associated with treatment failure. An increasingly used precise treatment is ""stereotactic brain radiosurgery"" (SRS), which avoids sensitive brain regions and can be used repeatedly if new metastases are later diagnosed, which happens in more than 50% of cases.
As in neurosurgery (NS), SRS relies on magnetic resonance imaging (MRI) for planning treatment. In NS, MRI provides the neurosurgeon with the optimal approach through the brain, avoiding important brain structures. In SRS, MRI provides the optimal path of the radiation beams. There is increasing interest in obtaining brain nerve fiber maps using an MRI technique called ""diffusion tensor imaging"" (DTI) for NS planning. DTI could also be used in SRS planning to minimize injury to important neural pathways and nerves, especially when patients have had previous SRS. Furthermore, DTI may improve detection of radiation damage to nerve fibers, and better delineate tumour boundary than with current imaging. However, DTI is very sensitive to spatial distortions, which currently limits its utility.
Synaptive Medical is a medical device/software company based in Toronto that has developed solutions for correcting and incorporating fiber tract visualization into NS planning (BrightMatterTM Plan), as well assessing incoming DTI scans for meeting minimum diagnostic requirements (BrightMatterTM Bridge). The main proposal objective is to investigate how Synaptive's solutions may improve SRS planning accuracy. Project milestones include evaluation of: currently used DTI protocols, functionality needed for SRS planning, ability to see BM boundary, and ability to visualize nerve fiber damage from SRS.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
488406-2015
Name nom
Sarfehnia, Arman
Department département
Radiation Oncology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3115
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Medical Physics
Research subject fr
Physique médicale
Partie
1
Nb partie
1
Application title
Investigation of nerve fibre imaging in radiosurgery
Keyword
NSERC
Application summary
20-40% of all cancer patients develop brain metastases (BM). The incidence is likely to increase as cancer patients are living longer. Effective treatment provides patients with a high quality of life, but must be efficient and accurate due to increasing patient numbers and the risks associated with treatment failure. An increasingly used precise treatment is ""stereotactic brain radiosurgery"" (SRS), which avoids sensitive brain regions and can be used repeatedly if new metastases are later diagnosed, which happens in more than 50% of cases.
As in neurosurgery (NS), SRS relies on magnetic resonance imaging (MRI) for planning treatment. In NS, MRI provides the neurosurgeon with the optimal approach through the brain, avoiding important brain structures. In SRS, MRI provides the optimal path of the radiation beams. There is increasing interest in obtaining brain nerve fiber maps using an MRI technique called ""diffusion tensor imaging"" (DTI) for NS planning. DTI could also be used in SRS planning to minimize injury to important neural pathways and nerves, especially when patients have had previous SRS. Furthermore, DTI may improve detection of radiation damage to nerve fibers, and better delineate tumour boundary than with current imaging. However, DTI is very sensitive to spatial distortions, which currently limits its utility.
Synaptive Medical is a medical device/software company based in Toronto that has developed solutions for correcting and incorporating fiber tract visualization into NS planning (BrightMatterTM Plan), as well assessing incoming DTI scans for meeting minimum diagnostic requirements (BrightMatterTM Bridge). The main proposal objective is to investigate how Synaptive's solutions may improve SRS planning accuracy. Project milestones include evaluation of: currently used DTI protocols, functionality needed for SRS planning, ability to see BM boundary, and ability to visualize nerve fiber damage from SRS.